1. Home
  2. Service & Software
  3. Global CRISPR-PE Technology Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global CRISPR-PE Technology Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 95 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global CRISPR-PE Technology market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the CRISPR-PE Technology market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of CRISPR-PE Technology in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Cell Line Engineering
Genome Regulation

Market Snapshot, By Application
Biomedical Research
Agricultural Research
Others

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
Synthego Corporation
Sangoma Therapeutics
Precision Bioscience
Intellia Therapeutics Inc.
Integrated DNA Technologies (IDT
Inscripta
Horizon Discovery
GenScript Biotech
CRISPR Therapeutics
Beam Therapeutics

The study objectives of this report are:
To study and analyze the global CRISPR-PE Technology market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of CRISPR-PE Technology market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global CRISPR-PE Technology manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the CRISPR-PE Technology market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of CRISPR-PE Technology submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of CRISPR-PE Technology are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 CRISPR-PE Technology Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global CRISPR-PE Technology Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and CRISPR-PE Technology

3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Application One
3.2.2 Major Buyers in Application Two
3.2.1 Major Buyers in Application Three

4 Market Segment: by Type
4.1 CRISPR-PE Technology Type Introduction
4.1.1 Cell Line Engineering
4.1.2 Genome Regulation
4.2 Global CRISPR-PE Technology Revenue by Type 2016-2021

5 Market Segment: by Application
5.1 CRISPR-PE Technology Type Introduction
5.1.1 Biomedical Research
5.1.2 Agricultural Research
5.1.3 Others
5.2 Global CRISPR-PE Technology Revenue by Application 2016-2021

6 Marke Segment: by Region
6.1 Global CRISPR-PE Technology Market by Region
6.2 North America CRISPR-PE Technology Market 2016-2021
6.3 Europe CRISPR-PE Technology Market 2016-2021
6.4 Asia Pacific CRISPR-PE Technology Market 2016-2021
6.5 South America CRISPR-PE Technology Market 2016-2021
6.6 Middle East and Africa CRISPR-PE Technology Market 2016-2021

7 North America
7.1 North America CRISPR-PE Technology Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe CRISPR-PE Technology Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific CRISPR-PE Technology Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America CRISPR-PE Technology Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa CRISPR-PE Technology Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
3.1 Synthego Corporation
3.1.1 Synthego Corporation Company Information
3.1.2 Synthego Corporation CRISPR-PE Technology Product Portfolio, Specification and Application
3.1.3 Synthego Corporation CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
3.1.4 Synthego Corporation Key Development
3.2 Sangoma Therapeutics
3.2.1 Sangoma Therapeutics Company Information
3.2.2 Sangoma Therapeutics CRISPR-PE Technology Product Portfolio, Specification and Application
3.2.3 Sangoma Therapeutics CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
3.2.4 Sangoma Therapeutics Key Development
3.3 Precision Bioscience
3.3.1 Precision Bioscience Company Information
3.3.2 Precision Bioscience CRISPR-PE Technology Product Portfolio, Specification and Application
3.3.3 Precision Bioscience CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
3.3.4 Precision Bioscience Key Development
3.4 Intellia Therapeutics Inc.
3.4.1 Intellia Therapeutics Inc. Company Information
3.4.2 Intellia Therapeutics Inc. CRISPR-PE Technology Product Portfolio, Specification and Application
3.4.3 Intellia Therapeutics Inc. CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
3.4.4 Intellia Therapeutics Inc. Key Development
3.5 Integrated DNA Technologies (IDT
3.5.1 Integrated DNA Technologies (IDT Company Information
3.5.2 Integrated DNA Technologies (IDT CRISPR-PE Technology Product Portfolio, Specification and Application
3.5.3 Integrated DNA Technologies (IDT CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
3.5.4 Integrated DNA Technologies (IDT Key Development
3.6 Inscripta
3.6.1 Inscripta Company Information
3.6.2 Inscripta CRISPR-PE Technology Product Portfolio, Specification and Application
3.6.3 Inscripta CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
3.6.4 Inscripta Key Development
3.7 Horizon Discovery
3.7.1 Horizon Discovery Company Information
3.7.2 Horizon Discovery CRISPR-PE Technology Product Portfolio, Specification and Application
3.7.3 Horizon Discovery CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
3.7.4 Inscripta Key Development
3.9 CRISPR Therapeutics
3.9.1 CRISPR Therapeutics Company Information
3.9.2 CRISPR Therapeutics CRISPR-PE Technology Product Portfolio, Specification and Application
3.9.3 CRISPR Therapeutics CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
3.9.4 CRISPR Therapeutics Key Development
3.8 GenScript Biotech
3.8.1 GenScript Biotech Company Information
3.8.2 GenScript Biotech CRISPR-PE Technology Product Portfolio, Specification and Application
3.8.3 GenScript Biotech CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
3.8.4 GenScript Biotech Key Development

13 Global CRISPR-PE Technology Market Forecast by Region by Type and by Application
13.1 Global CRISPR-PE Technology Revenue Forecast 2022-2027
13.2 Global CRISPR-PE Technology Forecast by Regions
13.3 Global CRISPR-PE Technology Forecast by Type
13.4 Global CRISPR-PE Technology Forecast by Application

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global CRISPR-PE Technology Production Specifications
Table 2: Drivers in CRISPR-PE Technology Market
Table 3: Restraints CRISPR-PE Technology Market
Table 4: Opportunity in CRISPR-PE Technology Market
Table 5: Comparion of Alternative and CRISPR-PE Technology
Table 6: CRISPR-PE Technology Raw Materials Key Suppliers List
Table 7: CRISPR-PE Technology Distributors List
Table 8: CRISPR-PE Technology Major Buyers in Application One
Table 9: CRISPR-PE Technology Major Buyers in Application Two
Table 10: CRISPR-PE Technology Major Buyers in Application Three
Table 11: Global CRISPR-PE Technology Revenue (Million USD) by Type 2016-2021
Table 12: Global CRISPR-PE Technology Revenue Market Share by Type 2016-2021
Table 18: Global CRISPR-PE Technology Revenue (Million USD) by Application 2016-2021
Table 19: Global CRISPR-PE Technology Revenue Market Share by Application 2016-2021
Table 20: Global CRISPR-PE Technology Revenue (Million USD) by Region 2016-2021
Table 21: Global CRISPR-PE Technology Revenue Market Share by Region 2016-2021
Table 22: North America CRISPR-PE Technology Revenue (Million USD) by Country 2016-2021
Table 23: North America CRISPR-PE Technology Revenue Market Share by Country 2016-2021)
Table 24: Europe CRISPR-PE Technology Revenue (Million USD) by Country 2016-2021
Table 25: Europe CRISPR-PE Technology Revenue Market Share by Country 2016-2021)
Table 26: Asia Pacific CRISPR-PE Technology Revenue (Million USD) by Country 2016-2021
Table 27: Asia Pacific CRISPR-PE Technology Revenue Market Share by Country 2016-2021)
Table 28: South America CRISPR-PE Technology Revenue (Million USD) by Country 2016-2021
Table 29: South America CRISPR-PE Technology Revenue Market Share by Country 2016-2021)
Table 30: Middle East and Africa CRISPR-PE Technology Revenue (Million USD) by Country 2016-2021
Table 31: Middle East and Africa CRISPR-PE Technology Revenue Market Share by Country 2016-2021)
Table 32 Synthego Corporation Company Information
Table 33 Synthego Corporation CRISPR-PE Technology Product Portfolio, Specification and Application
Table 34 Synthego Corporation CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
Table 35 Sangoma Therapeutics Company Information
Table 36 Sangoma Therapeutics CRISPR-PE Technology Product Portfolio, Specification and Application
Table 37 Sangoma Therapeutics CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
Table 38 Precision Bioscience Company Information
Table 39 Precision Bioscience CRISPR-PE Technology Product Portfolio, Specification and Application
Table 40 Precision Bioscience CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
Table 41 Intellia Therapeutics Inc. Company Information
Table 42 Intellia Therapeutics Inc. CRISPR-PE Technology Product Portfolio, Specification and Application
Table 43 Intellia Therapeutics Inc. CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
Table 44 Integrated DNA Technologies (IDT Company Information
Table 45 Integrated DNA Technologies (IDT CRISPR-PE Technology Product Portfolio, Specification and Application
Table 46 Integrated DNA Technologies (IDT CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
Table 47 Inscripta Company Information
Table 48 Inscripta CRISPR-PE Technology Product Portfolio, Specification and Application
Table 49 Inscripta CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
Table 50 Horizon Discovery Company Information
Table 51 Horizon Discovery CRISPR-PE Technology Product Portfolio, Specification and Application
Table 52 Horizon Discovery CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
Table 53 GenScript Biotech Company Information
Table 54 GenScript Biotech CRISPR-PE Technology Product Portfolio, Specification and Application
Table 55 GenScript Biotech CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
Table 56 CRISPR Therapeutics Company Information
Table 57 CRISPR Therapeutics CRISPR-PE Technology Product Portfolio, Specification and Application
Table 58 CRISPR Therapeutics CRISPR-PE Technology Revenue and Gross Margin (2019-2021)
Table 59: Global CRISPR-PE Technology Revenue (Million USD) Forecast by Region (2022-2027)
Table 60: Global CRISPR-PE Technology Revenue Market Share Forecast by Region (2022-2027)
Table 61: Global CRISPR-PE Technology Revenue (Million USD) Forecast by Type (2022-2027)
Table 62: Global CRISPR-PE Technology Revenue Market Share Forecast by Type (2022-2027)
Table 63: Global CRISPR-PE Technology Revenue (Million USD) Forecast by Application (2022-2027)
Table 64: Global CRISPR-PE Technology Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: CRISPR-PE Technology Picture
Figure 2: Global CRISPR-PE Technology Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: CRISPR-PE Technology Industry Life Cycle
Figure 5: Product Picture of Cell Line Engineering
Figure 6: Product Picture of Genome Regulation
Figure 9: Global CRISPR-PE Technology Revenue Market Share by Type, 2020


Reason to Buy

  • Current and future of Service & Software Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Service & Software Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Service & Software Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Service & Software Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets